Smugglers blamed as Lebanon bans cancer drug
BEIRUT: A drug used to treat cancer patients has been banned from sale in Lebanon following a World Health Organization alert on a contaminated batch of the product, which officials believe was smuggled into the country.
The WHO on Tuesday cited adverse effects in pediatric patients receiving the drug, and said that its product alert referred to a batch of substandard Methothrex (methotrexate), which had been identified in Yemen and Lebanon.
The drug, an immunosuppressant used to treat cancer and autoimmune diseases, is on the WHO model list of essential medicines.